The role of cFLIP in cardiac hypertrophy and fibrosis induced by chronic pressure overload

WANG Chun-yi,FAN Yang,WANG Xin-an,XIAO Jin-feng,LI Ming-jiang,LI Hong-liang,XIA Hao
DOI: https://doi.org/10.13333/j.cnki.cjcpe.2012.02.005
2012-01-01
Abstract:Objective To clarify the role of cellular Fas-associated death domain-like interleukin-1β-converting enzyme(FLICE)-like inhibitory protein(cFLIP)gene in cardiac hypertrophy and fibrosis induced by chronic pressure overload.Methods Twenty cFLIP heterozygote(HZ)mice and twenty wild-type cFLIP(WT)mice were randomly divided into model group and sham group equtionally(n=10).Cardiac hypertrophy model was established through aortic banding surgery.Four weeks after the aortic banding operation,cardiac function were evaluated by ultrasonic diagnosis equipment,and the degree of cardiac hypertrophy and fibrosis were evaluated by histological detection.In addition,the markers of cardiac hypertrophy including brain natriuretic peptide,atrial natriuretic peptide,and β-myosin heavy chain(β-MHC),fibrosis markers connective tissue growth factor(CTGF),transforming growth factor-β1(TGF-β1),and collagen Ⅰ,Ⅳ were detected by real-time quantitative polymerase chain reaction(PCR)at the mRNA level.Results Four weeks after the aortic banding operation,the physiological parameters and analysis of cardiac size and function of HZ group were reduced significantly(P<0.05,n=10),and the degree of cardiac hypertrophy and fibrosis were increased dramatically(P<0.05,n=10) while compared with those of WT group.Conclusion The cFLIP protects against the development of cardiac hypertrophy and fibrosis.
What problem does this paper attempt to address?